Serum autotaxin levels are associated with Graves’ disease - Araki, Osamu; Nishikawa, Masako; Aoki, Junken; Igarashi, Koji; Kihara, Shinji; Kano, Kuniyuki; Shimamoto, Satoshi; Kurano, Makoto; Murakami, Masami; Nojiri, Takahiro; Yatomi, Yutaka; Nakawatari, Kazuki (Endocrine Journal, 2019)
Keywords: 3T3-L1 Cells; Adipocytes; Adipocytes - drug effects; Adipocytes - metabolism; Animals; Anti-thyroid drugs; Antithyroid Agents - therapeutic use; Autotaxin; Graves Disease - blood; Graves Disease - drug therapy; Graves' disease; Humans; Hyperthyroidism; Isoforms; Lysophosphatidic acid; Lysophosphatidic acids; Mice; Pathogenesis; Phosphoric Diester Hydrolases - blood; Phosphoric Diester Hydrolases - metabolism; Serum levels; Thyroid diseases; Thyroid gland; Thyroid hormones; Thyroidectomy; Thyroiditis; Thyroiditis - blood; Thyroiditis - drug therapy; Thyroxine; Thyroxine - pharmacology; Triiodothyronine; Triiodothyronine - pharmacology; Lysophosphatidic acids; Thyroid hormones; Graves’ disease; Autotaxin; Anti-thyroid drugs